PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIOR vs. GGR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BIOR and GGR is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

BIOR vs. GGR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Biora Therapeutics Inc (BIOR) and Gogoro Inc (GGR). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-96.44%
-67.07%
BIOR
GGR

Key characteristics

Sharpe Ratio

BIOR:

-0.74

GGR:

-0.99

Sortino Ratio

BIOR:

-2.26

GGR:

-2.24

Omega Ratio

BIOR:

0.64

GGR:

0.75

Calmar Ratio

BIOR:

-0.97

GGR:

-0.82

Martin Ratio

BIOR:

-1.43

GGR:

-1.54

Ulcer Index

BIOR:

67.85%

GGR:

51.57%

Daily Std Dev

BIOR:

132.50%

GGR:

80.47%

Max Drawdown

BIOR:

-99.99%

GGR:

-97.29%

Current Drawdown

BIOR:

-99.99%

GGR:

-97.12%

Fundamentals

Market Cap

BIOR:

$994.99K

GGR:

$136.32M

EPS

BIOR:

$0.36

GGR:

-$0.31

Total Revenue (TTM)

BIOR:

$892.00K

GGR:

$237.51M

Gross Profit (TTM)

BIOR:

$677.00K

GGR:

$13.32M

EBITDA (TTM)

BIOR:

-$14.20M

GGR:

$30.19M

Returns By Period


BIOR

YTD

0.00%

1M

0.00%

6M

-96.66%

1Y

-97.28%

5Y*

N/A

10Y*

N/A

GGR

YTD

-14.93%

1M

-10.51%

6M

-66.53%

1Y

-78.31%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BIOR vs. GGR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIOR
The Risk-Adjusted Performance Rank of BIOR is 44
Overall Rank
The Sharpe Ratio Rank of BIOR is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of BIOR is 11
Sortino Ratio Rank
The Omega Ratio Rank of BIOR is 11
Omega Ratio Rank
The Calmar Ratio Rank of BIOR is 11
Calmar Ratio Rank
The Martin Ratio Rank of BIOR is 77
Martin Ratio Rank

GGR
The Risk-Adjusted Performance Rank of GGR is 33
Overall Rank
The Sharpe Ratio Rank of GGR is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of GGR is 11
Sortino Ratio Rank
The Omega Ratio Rank of GGR is 33
Omega Ratio Rank
The Calmar Ratio Rank of GGR is 44
Calmar Ratio Rank
The Martin Ratio Rank of GGR is 44
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BIOR vs. GGR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Biora Therapeutics Inc (BIOR) and Gogoro Inc (GGR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BIOR, currently valued at -0.74, compared to the broader market-2.000.002.004.00-0.74-0.97
The chart of Sortino ratio for BIOR, currently valued at -2.26, compared to the broader market-6.00-4.00-2.000.002.004.006.00-2.26-2.14
The chart of Omega ratio for BIOR, currently valued at 0.64, compared to the broader market0.501.001.502.000.640.76
The chart of Calmar ratio for BIOR, currently valued at -0.97, compared to the broader market0.002.004.006.00-0.97-0.80
The chart of Martin ratio for BIOR, currently valued at -1.43, compared to the broader market0.0010.0020.0030.00-1.43-1.50
BIOR
GGR

The current BIOR Sharpe Ratio is -0.74, which is comparable to the GGR Sharpe Ratio of -0.99. The chart below compares the historical Sharpe Ratios of BIOR and GGR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.10-1.00-0.90-0.80-0.70-0.60SeptemberOctoberNovemberDecember2025February
-0.74
-0.97
BIOR
GGR

Dividends

BIOR vs. GGR - Dividend Comparison

Neither BIOR nor GGR has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BIOR vs. GGR - Drawdown Comparison

The maximum BIOR drawdown since its inception was -99.99%, roughly equal to the maximum GGR drawdown of -97.29%. Use the drawdown chart below to compare losses from any high point for BIOR and GGR. For additional features, visit the drawdowns tool.


-100.00%-98.00%-96.00%-94.00%-92.00%-90.00%SeptemberOctoberNovemberDecember2025February
-99.93%
-97.12%
BIOR
GGR

Volatility

BIOR vs. GGR - Volatility Comparison

The current volatility for Biora Therapeutics Inc (BIOR) is 0.00%, while Gogoro Inc (GGR) has a volatility of 14.33%. This indicates that BIOR experiences smaller price fluctuations and is considered to be less risky than GGR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%SeptemberOctoberNovemberDecember2025February0
14.33%
BIOR
GGR

Financials

BIOR vs. GGR - Financials Comparison

This section allows you to compare key financial metrics between Biora Therapeutics Inc and Gogoro Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab